Pricing Log in Create free account

Parabilis Medicines, Inc. (PBLS) vs Tango Therapeutics, Inc. (TNGX)

Parabilis Medicines, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Parabilis Medicines, Inc. and Tango Therapeutics, Inc. are of similar size ($3.5B and $3.4B). Across the 10 metrics below, Parabilis Medicines, Inc. leads on 5 and Tango Therapeutics, Inc. on 5.

Valuation

Metric PBLS TNGX Biotechnology median
P/E n/m n/m 10.26
P/S n/m 50.96 9.18
P/B 0.77 3.10 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 1.79 n/m 0.65
EV/Sales n/m 34.70 8.98
Earnings yield (297.78%) (3.96%) (34.89%)
Free cash flow yield (14.78%) (4.54%) (24.52%)

Profitability

Metric PBLS TNGX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (21.34%) (50.12%)
Return on assets 0.00% (18.86%) (45.60%)
Return on invested capital 0.00% (808.35%) 0.00%

Growth

Metric PBLS TNGX Biotechnology median
Revenue growth (TTM) — 48.29% 6.26%
EPS growth (last fiscal year) (10.69%) 26.89% 29.88%
Revenue growth, 5-year CAGR — 52.13% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric PBLS TNGX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 17.91 50.82 4.89
Net debt to EBITDA 0.09 3.08 1.01

Dividend

Metric PBLS TNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PBLS TNGX Biotechnology median
Market cap 3.44b 3.52b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack